Banks including Goldman Sachs Group Inc and Citigroup Inc. are among 22 banks set to provide Clayton Dubilier & Rice with ...
Clayton Dubilier & Rice is working on a package of commitments amid political concerns that its purchase of a controlling ...
Operating independently within Sanofi, Opella has resources allocated for research and development, production, and digital ...
Clayton Dubilier & Rice is nearing a deal to acquire Sanofi’s consumer health unit for about €15 billion ($16.4 billion), in ...
Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity ...
The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...
(Reuters) - Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for ...
France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...
The proposal from PAI Partners, challenging a US bidder, is the latest twist in a battle to win a 50% stake in Opella, the ...
PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.
A consortium led by French private equity firm PAI Partners has submitted an increased offer for Sanofi's (SASY) consumer health ...